Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study

Repeatability of 18 F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma

(2016) Martin A. Lodge et al.   JOURNAL OF NUCLEAR MEDICINE

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

(2014) Ronald Boellaard et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Comparison of the Amino Acid Tracers 18F-FET and 18F-DOPA in High-Grade Glioma Patients

(2014) C. Lapa et al.   JOURNAL OF NUCLEAR MEDICINE

Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients

(2014) M. Hutterer et al.   NEURO-ONCOLOGY

An Intra-Individual Comparison of MRI, [18F]-FET and [18F]-FLT PET in Patients with High-Grade Gliomas

(2014) Martha Nowosielski et al.   PLoS One

Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy

(2013) Olivier L. Chinot et al.   Current Neurology and Neuroscience Reports

Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors

(2013) Clemens Kratochwil et al.   NEURO-ONCOLOGY

[18F]-fluoro-ethyl-l-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma

(2013) Markus Hutterer et al.   NEURO-ONCOLOGY

Comparison of 18F-Fluorodeoxyglucose and 18F-Fluorothymidine PET in Differentiating Radiation Necrosis From Recurrent Glioma

(2012) Michael S. Enslow et al.   CLINICAL NUCLEAR MEDICINE

Value of 11C-methionine PET in imaging brain tumours and metastases

(2012) Andor W. J. M. Glaudemans et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI

(2012) Norbert Galldiks et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

3'-Deoxy-3'-18F-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients

(2012) A. J. S. Idema et al.   JOURNAL OF NUCLEAR MEDICINE

Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis

(2012) V. Dunet et al.   JOURNAL OF NUCLEAR MEDICINE

Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis

(2012) Charles M. Laymon et al.   MAGNETIC RESONANCE IMAGING

18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab

(2012) R. J. Harris et al.   NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009

(2012) T. A. Dolecek et al.   NEURO-ONCOLOGY

Diagnostic Value of 11C-Methionine (MET) and 18F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis

(2012) Hajime Shishido et al.   Cancers

Discriminant Analysis of 18F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma

(2011) M. Wardak et al.   CLINICAL CANCER RESEARCH

Pseudoprogression: Relevance With Respect to Treatment of High-Grade Gliomas

(2011) James Fink et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Diagnostic Usefulness of 3’-Deoxy-3’-[18F]Fluorothymidine Positron Emission Tomography in Recurrent Brain Tumor

(2011) Il Ki Hong et al.   JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY

3'-Deoxy-3'-18F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with Bevacizumab

(2011) J. Schwarzenberg et al.   JOURNAL OF NUCLEAR MEDICINE

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Kinetics of 3'-Deoxy-3'-18F-Fluorothymidine During Treatment Monitoring of Recurrent High-Grade Glioma

(2010) C. Schiepers et al.   JOURNAL OF NUCLEAR MEDICINE

Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma

(2009) Heiko Backes et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

(2009) Ronald Boellaard et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies

(2009) L. M. Velasquez et al.   JOURNAL OF NUCLEAR MEDICINE

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies

(2009) Alexander M. Spence et al.   MOLECULAR IMAGING AND BIOLOGY

[18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer

(2009) Lukas B. Been et al.   ORAL ONCOLOGY

Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

(2008) Walter Taal et al.   CANCER

Glioma Proliferation as Assessed by 3'-Fluoro-3'-Deoxy-L-Thymidine Positron Emission Tomography in Patients with Newly Diagnosed High-Grade Glioma

(2008) R. Ullrich et al.   CLINICAL CANCER RESEARCH

Imaging regional variation of cellular proliferation in gliomas using 3′-deoxy-3′-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study

(2008) S.J. Price et al.   CLINICAL RADIOLOGY

The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials

(2008) Ronald Boellaard et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

(2008) Dieta Brandsma et al.   LANCET ONCOLOGY